Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancerLisa Derosa, Benjamin Besse, Julien Mazières et al.|Nature Medicine|2022Cited by 637
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real-world multicentre studyAntoine Desîlets, Arielle Elkrief, Félix Blanc‐Durand et al.|European Journal of Cancer|2020Cited by 78
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapyArielle Elkrief, Adam J. Schoenfeld, Eder Orlando Méndez-Salazar et al.|npj Precision Oncology|2024Cited by 54